InvestorsHub Logo

biomanbaba

10/16/13 3:35 PM

#1320 RE: BRZlimited92 #1318

The most important new thing I can say today is in post 1319 and beyond that since you are new this tool below allows you to read all of my post on this board without hunting
http://investorshub.advfn.com/boards/memberpoststoboard.aspx?userid=3594&boardid=7999

biomanbaba

10/17/13 4:01 AM

#1333 RE: BRZlimited92 #1318

Dr Feldman is in charge of this Trial

therefore KNOWING who she is gives me great confidence

Feldman is the author of more than 260 articles, 59 book chapters and 3 books. She is the Principal Investigator of 4 major National Institutes of Health research grants, 3 private foundation grants and 5 clinical trials focused on understanding and treating neurological disorders, with an emphasis on ALS and diabetic neuropathy. She is President of the American Neurological Association and recent Past President of the Peripheral Nerve Society.She was recently chair of the Complications Council of the American Diabetes Association and served on the Scientific Advisory Board for the Juvenile Diabetes Research Foundation (JDRF).
She serves on numerous editorial boards and she is the Neurology Consultant to the Epidemiology of Diabetes Intervention and Complications Trial (EDIC) for the National Institutes of Health (NIH).
Feldman has received many honors including the Early Distinguished Career Award and the Distinguished Faculty Achievement Award from the University of Michigan, several scientific achievement awards in the field of diabetes and election to the Johns Hopkins Society of Scholars. Additionally, she has been listed in Best Doctors in America for more than 10 consecutive years.
Among Dr. Feldman’s greatest accomplishments is her training of both scientists and neurologists. Nine scientists have received their Ph.D. degrees under her, she has trained 40 postdoctoral fellows in her laboratory to become neuroscientists, and 36 neurologists have trained under her to specialize in the understanding and treatment of neuromuscular diseases, with an emphasis on ALS.